Immutep Limited American Depositary Shares (IMMP) Stock Price

IMMPStock

$0.38−78.82%52W

Market Cap$56.28M

P/E—

PEG Ratio—

Div yield—

Beta2.64

IMMP Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-96.65%

Price vs S&P 500 (4W)11.84%

VGM Score52.71

Book Value / Share (Quarterly)$0.05

P/TBV (Annual)2.57x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-49.93%

Cash Flow / Share (Quarterly)$0.00

Price vs S&P 500 (YTD)-98.74%

Net Profit Margin (TTM)-2030.67%

EPS (TTM)$-0.04

10-Day Avg Trading Volume5.54M

EPS Excl Extra (TTM)$-0.04

Revenue Growth (5Y)-66.35%

EPS (Annual)$-0.03

ROI (Annual)-42.29%

Net Profit Margin (5Y Avg)-31067.06%

Cash / Share (Quarterly)$0.05

Revenue Growth QoQ (YoY)17606.36%

ROA (Last FY)-39.13%

Revenue Growth TTM (YoY)7574.00%

EBITD / Share (TTM)$-0.04

ROE (5Y Avg)-33.92%

Operating Margin (TTM)-2153.84%

Cash Flow / Share (Annual)$-0.02

P/B Ratio0.77x

P/B Ratio (Quarterly)6.41x

EV / Revenue (TTM)1.23x

Net Interest Coverage (TTM)-2.30x

ROA (TTM)-55.17%

EPS Incl Extra (Annual)$-0.03

Current Ratio (Annual)11.69x

Quick Ratio (Quarterly)2.91x

3-Month Avg Trading Volume18.86M

52-Week Price Return-78.82%

Tangible BV / Share (Quarterly)$0.05

P/S Ratio (Annual)1275.10x

Asset Turnover (Annual)0.00x

52-Week High$0.34

Operating Margin (5Y Avg)-34985.03%

EPS Excl Extra (Annual)$-0.03

CapEx CAGR (5Y)86.31%

Tangible BV CAGR (5Y)49.61%

26-Week Price Return-85.41%

Quick Ratio (Annual)11.02x

13-Week Price Return-3.57%

Total Debt / Equity (Annual)0.01x

Current Ratio (Quarterly)2.97x

Enterprise Value$3.65M

Asset Turnover (TTM)0.03x

Book Value / Share Growth (5Y)7.93%

Pretax Margin (Annual)-102219.92%

Cash / Share (Annual)$0.06

3-Month Return Std Dev53.26%

ROE (Last FY)-42.77%

Net Interest Coverage (Annual)-101.51x

EPS Basic Excl Extra (Annual)$-0.03

Receivables Turnover (TTM)0.26x

EV / Free Cash Flow (TTM)124.36x

Total Debt / Equity (Quarterly)0.01x

EPS Incl Extra (TTM)$-0.04

Receivables Turnover (Annual)0.10x

ROI (TTM)-68.40%

P/S Ratio (TTM)18.54x

Pretax Margin (5Y Avg)-31067.05%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.07

Price vs S&P 500 (52W)-97.13%

Year-to-Date Return-86.99%

5-Day Price Return5.88%

EPS Normalized (Annual)$-0.03

ROA (5Y Avg)-31.07%

Net Profit Margin (Annual)-102219.92%

Month-to-Date Return17.39%

Cash Flow / Share (TTM)$-0.03

EBITD / Share (Annual)$-0.03

Operating Margin (Annual)-116703.91%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-33.31%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.04

P/TBV (Quarterly)6.81x

P/B Ratio (Annual)2.44x

Pretax Margin (TTM)-2030.67%

Book Value / Share (Annual)$0.07

Price vs S&P 500 (13W)-6.37%

Beta2.64x

Revenue / Share (TTM)$0.00

ROE (TTM)-69.20%

52-Week Low$0.02

vGradeB

gGradeB

mGradeD

vgmGradeC

IMMP Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.63

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
IMMPImmutep Limited American Depositary Shares	B	B	D	$0.38
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Immutep Limited American Depositary Shares

Immutep is a Phase 3 clinical-stage biotechnology company developing LAG-3 immunotherapies to treat cancer and autoimmune diseases. Its lead candidate, eftilagimod alfa (efti), is in a registrational Phase 3 trial for first-line non-small cell lung cancer. The company's diversified pipeline includes additional LAG-3-based programs targeting various solid tumors and autoimmune indications.